サケカルシトニン

使用用途

• Hypervitaminosis D (toxicity)/hypercalcemia
• Hypervitaminosis D (toxicity)/hypercalcemia
• Adjunctive therapy if fluid deficit replacement, saline diuresis, furosemide and prednisone have failed to control calcium
• Hypervitaminosis D (toxicity)/hypercalcemia
• Hypercalcemia (Green iguanas)
• Nutritional secondary hyperparathyroidism (NSHP)
• Nutritional secondary hyperparathyroidism (NSHP)

投与方法

考えられる副作用

• Anorexia
• Vomiting
• Hypocalcemia (with overmedication)
• Diarrhea
• Injection site pain and swelling
• Redness
• Peripheral paresthesias (reported in humans)
• Allergic reactions (rare)
• Tachyphylaxis (resistance to therapy over time)

注意事項と禁忌

• Hypersensitivity to calcitonin
• Patients with a history of hypersensitivity to other proteins may be at risk
• > **Important Warnings** * **Age Sensitivity**: Young animals are reportedly up to 100 times more sensitive to the effects of calcitonin than older adult animals. * **Tachyphylaxis**: Resistance to the drug's effects frequently develops after several days of treatment. * **Pregnancy**: FDA Category C. Very high doses have decreased birth weights in laboratory animals due to metabolic effects. It does not cross the placenta. * **Lactation**: Calcitonin has been shown to inhibit lactation. Safe use during nursing has not been established.

薬物相互作用

• Vitamin D analogs: May interfere with the efficacy of calcitonin
• Calcium products: May interfere with the efficacy of calcitonin

よくある質問